OpenVSafe by OpenVAERS
Search V-safe

F93-26872-23867

4 vaccinations 12 coded responses 24 check-ins 11 free-text entries 6 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
420 / KY
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2280937 (opens in a new window) high 9 / 11 3 2 of 14 VAERS symptoms same dose (2) KY matches 2021-02-12 / 2021-05-15 / 2022-05-17
received the same day as the last call
case 935892

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-01-14
    Registered in v-safe
  2. 2021-01-14
    Dose 1 — Moderna
  3. 2021-01-14
    Survey response — day 0, dose 1
    MedDRA: Liver transplant, Pre-existing disease — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Immuno suppressed liver transplant
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Glucose level 150 points above normal with a significantly lower carb intake. Essentially no exercise today. Symptoms similar to the flu.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Glucose level 130 points above my established normal
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased, Blood insulin increased — Feeling: Good · Headache
    Free text: Glucose readings remain about 20 points higher than average following an increase in insulin. These numbers are lower than yesterday.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased — Feeling: Good · Headache, Muscle or body aches
    Free text: Very high glucose150 dg/ml.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Unevaluable event — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Glucose level has returned to normal.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-19
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-01-21
    Survey response — day 7, dose 1
    MedDRA: Blood glucose increased — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Spiking glucose following very light meal
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-28
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-02-04
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-11
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-02-12
    Dose 2 — Moderna
  15. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-19
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches
    Adult check-in
  17. 2021-02-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-24
  22. 2021-03-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-08-13
    Survey response — 6 months, dose 2
    MedDRA: Hospitalisation, Infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Hospital admitted for 4 days. Unknown pathogen. Recovering slowly.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-08-13
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  26. 2021-08-16
    Dose 3 — Moderna
  27. 2021-08-18
  28. 2021-11-15
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  29. 2022-02-14
    Dose 4 — Moderna
  30. 2022-02-14
    Survey response — 6 months, dose 3
    MedDRA: Asthenia, Feeling cold, Headache, Lymphoma, Sluggishness, Systemic scleroderma — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Sluggish, headache, loss of energy, physically cold. Cancer of lymph nodes, SSC on scalp
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-02-14
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  32. 2022-02-16
  33. 2022-05-16
    Survey response — 3 months, dose 4
    MedDRA: Lymphadenectomy, Lymphoma, Radiotherapy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Lymph node SCC followed by left lymph node dissection. Started radiation treatments last week.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-05-16
    Report sent to call center — 3 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  35. 2022-05-17
    Call successful
    Completed over the phone
  36. 2022-05-17
    Call successful
    Completed over the phone
  37. 2022-05-17
    Call successful
    Completed over the phone
  38. 2022-05-17
    Call successful
    Completed over the phone
  39. 2022-08-15
    Survey response — 6 months, dose 4
    MedDRA: Ageusia, Asthenia, Decreased appetite — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Loss of taste and no appetite. Lack of energy.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-08-15
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  41. 2022-08-16
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  42. 2023-02-14
    Survey response — 12 months, dose 4
    MedDRA: Herpes zoster, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    MedDRA releases: 2024-11
  43. 2023-02-14
    Report sent to call center — 12 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
  44. 2023-02-15

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Moderna
22021-02-12Moderna
32021-08-16Moderna No
42022-02-14Moderna No

Call center

6 call center cases

5 successful · 1 unsuccessful

VAERS report filed, before or during a call: 4

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-14

Systemic reaction (other): Immuno suppressed liver transplant

Release 2 — days 1–6 daily, dose 1

2021-01-15

Systemic reaction (other): Glucose level 150 points above normal with a significantly lower carb intake. Essentially no exercise today. Symptoms similar to the flu.

2021-01-16

Systemic reaction (other): Glucose level 130 points above my established normal

2021-01-17

Systemic reaction (other): Glucose readings remain about 20 points higher than average following an increase in insulin. These numbers are lower than yesterday.

2021-01-18

Systemic reaction (other): Very high glucose150 dg/ml.

2021-01-19

Systemic reaction (other): Glucose level has returned to normal.

Release 2 — day 7, dose 1

2021-01-21

Systemic reaction (other): Spiking glucose following very light meal

Release 9 — 6 months, dose 2

2021-08-13

Symptoms: Hospital admitted for 4 days. Unknown pathogen. Recovering slowly.

Release 11 — 6 months, dose 3

2022-02-14

Symptoms: Sluggish, headache, loss of energy, physically cold. Cancer of lymph nodes, SSC on scalp

Release 11 — 3 months, dose 4

2022-05-16

Symptoms: Lymph node SCC followed by left lymph node dissection. Started radiation treatments last week.

Release 12 — 6 months, dose 4

2022-08-15

Symptoms: Loss of taste and no appetite. Lack of energy.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAsthenia · · ✓
SDDecreased appetite · · ✓
SDFeeling cold · · ✓
SDHeadache · · ✓
SDHerpes zoster · · ✓
SDHospitalisation ✓ · ✓
SDInfection ✓ · ✓
SDLymphadenectomy · · ✓
SDLymphoma · · ✓
SDPre-existing disease · · ✓
SDRadiotherapy · · ✓
SDSluggishness · · ✓
SDSystemic scleroderma · · ✓
SROBlood glucose increased ✓ ✓ ✓
SROBlood insulin increased ✓ ✓ ✓
SROLiver transplant ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release